Latest Industry Insights
Industry Insight
Beyond Mutations: Inside Immuto’s Quest To Decode Disease Structure
Immuto Scientific’s structural surfaceomics platform reveals how wild-type proteins adopt disease-specific shapes that drive pathology. Immuto identifies previously invisible drug targets and designs conformation-selective therapies.
Industry Insight
AI-Powered Platforms Are Making Complex Data Usable for Drug Discovery
In this interview, we explore how Sonrai is advancing reproducible science, enabling cross-disciplinary collaboration and shaping the future of AI-powered drug discovery.
Industry Insight
How AI Is Accelerating the Digital Transformation of Pathology
Technology Networks spoke with Dr. Olga Colgan and Dr. Joseph Chiweshe to learn how AI-driven digital pathology is reshaping diagnostic workflows.
Industry Insight
Circular RNA: The Next Frontier for RNA Therapeutics?
Discover how circular RNA and targeted delivery technologies are advancing RNA therapeutics for chronic diseases and vaccines.
Industry Insight
Can Patients Trust a Drug Designed By AI?
Patient trust is vital as AI transforms pharma and drug discovery. Discover how transparency and regulation are making innovation safer.
Industry Insight
Genomics Testing Needs Structured Data To Succeed
Dr. Heidi Rehm shares insights on how genomics is evolving at the intersection of research and clinical practice. In this Q&A, she highlights the role of AI, global data standards and collaboration in shaping future patient care.
Industry Insight
Building Infinity™: How GeneDx Is Transforming Rare Disease Diagnosis
Families with rare diseases often wait years for answers. GeneDx’s AI-driven dataset, Infinity™, is changing that. In this interview, Dr. Bryan Dechario explains how decades of data are reshaping the future of genomic medicine.
Industry Insight
Advances in Deep Visual Proteomics With Dr. Andreas Mund
Deep Visual Proteomics integrates high-resolution imaging, AI and ultra-sensitive mass spectrometry to map proteins at single-cell resolution while preserving spatial context.
Industry Insight
Tomorrow, Today: Experts Discuss the Lab of the Future
In this article, we explore how AI, robotics and advanced software are transforming biopharma labs, the challenges of adopting these technologies and the vision for the “Lab of the Future.”
Industry Insight
How Nanoparticles Are Revolutionizing Drug Delivery
In this interview, Dr. Freya Leech, a researcher at NanoFCM, discusses the current challenges and future prospects in nanoparticle drug delivery.
Advertisement